Bluebird Capital Stock from 2010 to 2024

BLUE Stock

USD 0.36 0.01 2.86%

Bluebird Bio's Capital Stock is increasing over the years with slightly volatile fluctuation. Capital Stock is expected to dwindle to about 955.5 K. Capital Stock is the total amount of a company's capital funded by shareholders through the issue and subscription of shares. View All Fundamentals

Capital Stock

First Reported

2010-12-31

Previous Quarter

1.9 M

Current Value

955.5 K

Quarterly Volatility

355.3 K

Credit Downgrade

Yuan Drop

Covid

Check Bluebird Bio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Bluebird Bio's main balance sheet or income statement drivers, such as Depreciation And Amortization of 8 M, Interest Expense of 31.6 M or Selling General Administrative of 126.8 M, as well as many indicators such as Price To Sales Ratio of 4.88, Dividend Yield of 0.0 or PTB Ratio of 0.46. Bluebird financial statements analysis is a perfect complement when working with Bluebird Bio Valuation or Volatility modules.

Check out the analysis of Bluebird Bio Correlation against competitors.

For information on how to trade Bluebird Stock refer to our How to Trade Bluebird Stock guide.

Latest Bluebird Bio's Capital Stock Growth Pattern

Below is the plot of the Capital Stock of Bluebird bio over the last few years. It is the total amount of a company's capital funded by shareholders through the issue and subscription of shares. Bluebird Bio's Capital Stock historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Bluebird Bio's overall financial position and show how it may be relating to other accounts over time.

Capital Stock

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Capital Stock

Timeline

Bluebird Capital Stock Regression Statistics

	Arithmetic Mean	702,902
	Geometric Mean	654,566
	Coefficient Of Variation	50.55
	Mean Deviation	211,990
	Median	547,000
	Standard Deviation	355,311
	Sample Variance	126.2B
	Range	1.4M
	R-Value	0.60
	Mean Square Error	86.3B
	R-Squared	0.37
	Significance	0.02
	Slope	48,024
	Total Sum of Squares	1.8T

Bluebird Capital Stock History

	2024	955.5 K
	2023	1.9 M
	2022	830 K
	2021	711 K
	2020	665 K
	2019	554 K

Other Fundumenentals of Bluebird bio

Issuance Of Capital Stock

Bluebird Bio Capital Stock component correlations

	Total Assets	Total Stockholder Equity	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Short Term Investments	Total Liab	Total Current Assets	Short Term Debt	Common Stock	Property Plant Equipment	Net Tangible Assets	Long Term Debt	Net Receivables	Good Will	Capital Surpluse	Deferred Long Term Liab	Intangible Assets	Long Term Investments	Long Term Debt Total	Short Long Term Debt	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.96	0.56	-0.42	-0.24	0.56	0.92	0.69	0.95	-0.07	0.45	0.52	0.94	0.7	0.31	0.84	0.55	-0.32	0.51	0.75	0.64	0.64	0.14	0.1	-0.1
Total Stockholder Equity	0.96		0.67	-0.61	-0.02	0.45	0.95	0.55	0.98	-0.29	0.24	0.3	0.99	0.59	0.09	0.83	0.41	-0.32	0.54	0.84	0.5	0.51	0.35	0.31	-0.25
Current Deferred Revenue	0.56	0.67		-0.78	0.29	0.14	0.57	0.06	0.68	-0.48	-0.05	-0.06	0.65	0.08	-0.19	0.5	-0.01	-0.46	0.41	0.52	0.07	0.09	0.51	0.47	-0.35
Net Debt	-0.42	-0.61	-0.78		-0.57	0.08	-0.47	0.2	-0.65	0.71	0.37	0.36	-0.62	0.06	0.54	-0.44	0.25	0.25	-0.41	-0.55	0.12	0.1	-0.7	-0.7	0.58
Retained Earnings	-0.24	-0.02	0.29	-0.57		-0.61	-0.03	-0.74	-0.04	-0.79	-0.92	-0.81	0.04	-0.74	-0.77	-0.13	-0.89	0.37	0.07	0.19	-0.82	-0.8	0.91	0.92	-0.67
Accounts Payable	0.56	0.45	0.14	0.08	-0.61		0.51	0.76	0.46	0.31	0.6	0.49	0.42	0.76	0.58	0.43	0.74	-0.36	0.16	0.19	0.75	0.76	-0.39	-0.43	0.2
Short Term Investments	0.92	0.95	0.57	-0.47	-0.03	0.51		0.59	0.91	-0.34	0.17	0.23	0.96	0.56	0.06	0.76	0.42	-0.28	0.41	0.76	0.47	0.48	0.38	0.33	-0.3
Total Liab	0.69	0.55	0.06	0.2	-0.74	0.76	0.59		0.56	0.43	0.76	0.79	0.52	0.91	0.62	0.49	0.91	-0.37	0.15	0.24	0.91	0.92	-0.44	-0.47	0.46
Total Current Assets	0.95	0.98	0.68	-0.65	-0.04	0.46	0.91	0.56		-0.29	0.25	0.31	0.98	0.6	0.06	0.8	0.42	-0.38	0.5	0.76	0.54	0.55	0.32	0.29	-0.22
Short Term Debt	-0.07	-0.29	-0.48	0.71	-0.79	0.31	-0.34	0.43	-0.29		0.8	0.76	-0.36	0.45	0.82	0.02	0.53	0.04	0.07	-0.35	0.5	0.47	-0.9	-0.89	0.74
Common Stock	0.45	0.24	-0.05	0.37	-0.92	0.6	0.17	0.76	0.25	0.8		0.9	0.16	0.8	0.83	0.4	0.87	-0.35	0.24	0.03	0.84	0.81	-0.79	-0.81	0.63
Property Plant Equipment	0.52	0.3	-0.06	0.36	-0.81	0.49	0.23	0.79	0.31	0.76	0.9		0.25	0.78	0.85	0.37	0.78	-0.2	0.19	0.16	0.83	0.8	-0.66	-0.69	0.63
Net Tangible Assets	0.94	0.99	0.65	-0.62	0.04	0.42	0.96	0.52	0.98	-0.36	0.16	0.25		0.55	0.04	0.78	0.37	-0.3	0.48	0.85	0.46	0.48	0.41	0.37	-0.29
Long Term Debt	0.7	0.59	0.08	0.06	-0.74	0.76	0.56	0.91	0.6	0.45	0.8	0.78	0.55		0.62	0.55	0.94	-0.37	0.24	0.38	0.97	0.97	-0.47	-0.51	0.42
Net Receivables	0.31	0.09	-0.19	0.54	-0.77	0.58	0.06	0.62	0.06	0.82	0.83	0.85	0.04	0.62		0.25	0.65	-0.06	0.19	0.07	0.66	0.62	-0.71	-0.74	0.68
Good Will	0.84	0.83	0.5	-0.44	-0.13	0.43	0.76	0.49	0.8	0.02	0.4	0.37	0.78	0.55	0.25		0.4	-0.28	0.87	0.64	0.43	0.43	0.14	0.12	-0.13
Capital Surpluse	0.55	0.41	-0.01	0.25	-0.89	0.74	0.42	0.91	0.42	0.53	0.87	0.78	0.37	0.94	0.65	0.4		-0.52	0.1	0.16	0.95	0.95	-0.64	-0.68	0.54
Deferred Long Term Liab	-0.32	-0.32	-0.46	0.25	0.37	-0.36	-0.28	-0.37	-0.38	0.04	-0.35	-0.2	-0.3	-0.37	-0.06	-0.28	-0.52		-0.14	-0.02	-0.45	-0.47	0.2	0.23	-0.13
Intangible Assets	0.51	0.54	0.41	-0.41	0.07	0.16	0.41	0.15	0.5	0.07	0.24	0.19	0.48	0.24	0.19	0.87	0.1	-0.14		0.47	0.12	0.11	0.17	0.17	-0.06
Long Term Investments	0.75	0.84	0.52	-0.55	0.19	0.19	0.76	0.24	0.76	-0.35	0.03	0.16	0.85	0.38	0.07	0.64	0.16	-0.02	0.47		0.23	0.25	0.46	0.41	-0.32
Long Term Debt Total	0.64	0.5	0.07	0.12	-0.82	0.75	0.47	0.91	0.54	0.5	0.84	0.83	0.46	0.97	0.66	0.43	0.95	-0.45	0.12	0.23		1.0	-0.56	-0.6	0.49
Short Long Term Debt	0.64	0.51	0.09	0.1	-0.8	0.76	0.48	0.92	0.55	0.47	0.81	0.8	0.48	0.97	0.62	0.43	0.95	-0.47	0.11	0.25	1.0		-0.54	-0.57	0.48
Net Invested Capital	0.14	0.35	0.51	-0.7	0.91	-0.39	0.38	-0.44	0.32	-0.9	-0.79	-0.66	0.41	-0.47	-0.71	0.14	-0.64	0.2	0.17	0.46	-0.56	-0.54		1.0	-0.71
Net Working Capital	0.1	0.31	0.47	-0.7	0.92	-0.43	0.33	-0.47	0.29	-0.89	-0.81	-0.69	0.37	-0.51	-0.74	0.12	-0.68	0.23	0.17	0.41	-0.6	-0.57	1.0		-0.71
Capital Stock	-0.1	-0.25	-0.35	0.58	-0.67	0.2	-0.3	0.46	-0.22	0.74	0.63	0.63	-0.29	0.42	0.68	-0.13	0.54	-0.13	-0.06	-0.32	0.49	0.48	-0.71	-0.71

Click cells to compare fundamentals

About Bluebird Bio Financial Statements

Bluebird Bio stakeholders use historical fundamental indicators, such as Bluebird Bio's Capital Stock, to determine how well the company is positioned to perform in the future. Although Bluebird Bio investors may analyze each financial statement separately, they are all interrelated. For example, changes in Bluebird Bio's assets and liabilities are reflected in the revenues and expenses on Bluebird Bio's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Bluebird bio. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Capital Stock	1.9 M	955.5 K
Issuance Of Capital Stock	248.2 M	288.6 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America

When determining whether Bluebird bio is a strong investment it is important to analyze Bluebird Bio's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Bluebird Bio's future performance. For an informed investment choice regarding Bluebird Stock, refer to the following important reports:

How To Invest In Bluebird

Details

Is Bluebird Stock a good investment?

Details

What is Bluebird Bio's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out the analysis of Bluebird Bio Correlation against competitors.

For information on how to trade Bluebird Stock refer to our How to Trade Bluebird Stock guide.

You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bluebird Bio. If investors know Bluebird will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bluebird Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(1.80)

Revenue Per Share

0.357

Quarterly Revenue Growth

1.337

Return On Assets

(0.36)

Return On Equity

(1.87)

The market value of Bluebird bio is measured differently than its book value, which is the value of Bluebird that is recorded on the company's balance sheet. Investors also form their own opinion of Bluebird Bio's value that differs from its market value or its book value, called intrinsic value, which is Bluebird Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bluebird Bio's market value can be influenced by many factors that don't directly affect Bluebird Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Bluebird Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bluebird Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bluebird Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Bluebird Capital Stock from 2010 to 2024

Latest Bluebird Bio's Capital Stock Growth Pattern

Bluebird Capital Stock Regression Statistics

Bluebird Capital Stock History

Other Fundumenentals of Bluebird bio

Bluebird Bio Capital Stock component correlations

About Bluebird Bio Financial Statements

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY